[go: up one dir, main page]

SE8304857L - Farmaceutiska kompositioner - Google Patents

Farmaceutiska kompositioner

Info

Publication number
SE8304857L
SE8304857L SE8304857A SE8304857A SE8304857L SE 8304857 L SE8304857 L SE 8304857L SE 8304857 A SE8304857 A SE 8304857A SE 8304857 A SE8304857 A SE 8304857A SE 8304857 L SE8304857 L SE 8304857L
Authority
SE
Sweden
Prior art keywords
compositions
pharmaceutical compositions
preferred
base
ceftazidime
Prior art date
Application number
SE8304857A
Other languages
English (en)
Other versions
SE464615B (sv
SE8304857D0 (sv
Inventor
B L Richardson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of SE8304857D0 publication Critical patent/SE8304857D0/sv
Publication of SE8304857L publication Critical patent/SE8304857L/sv
Publication of SE464615B publication Critical patent/SE464615B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
SE8304857A 1982-09-10 1983-09-09 Fast farmaceutisk komposition med foerbaettrad stabilitet innehaallande ett eller flera beta-laktamantibiotika SE464615B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8225853 1982-09-10

Publications (3)

Publication Number Publication Date
SE8304857D0 SE8304857D0 (sv) 1983-09-09
SE8304857L true SE8304857L (sv) 1984-03-11
SE464615B SE464615B (sv) 1991-05-27

Family

ID=10532830

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8304857A SE464615B (sv) 1982-09-10 1983-09-09 Fast farmaceutisk komposition med foerbaettrad stabilitet innehaallande ett eller flera beta-laktamantibiotika

Country Status (20)

Country Link
US (2) US4582830A (sv)
JP (1) JPS5973518A (sv)
KR (1) KR880001094B1 (sv)
AT (1) AT388671B (sv)
AU (1) AU566245B2 (sv)
BE (1) BE897721A (sv)
CA (1) CA1215647A (sv)
CH (1) CH655008A5 (sv)
DE (1) DE3332616C2 (sv)
DK (1) DK161304C (sv)
ES (1) ES525492A0 (sv)
FR (1) FR2532849B1 (sv)
GB (1) GB2126479B (sv)
IE (1) IE55720B1 (sv)
IT (1) IT1197708B (sv)
NL (1) NL189948C (sv)
NZ (1) NZ205539A (sv)
PT (1) PT77323B (sv)
SE (1) SE464615B (sv)
ZA (1) ZA836703B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626534A (en) * 1984-07-23 1986-12-02 Eli Lilly And Company Pharmaceutical formulation
AT393452B (de) * 1985-08-05 1991-10-25 Bristol Myers Squibb Co Verfahren zur herstellung eines cephalosporinpraeparates zur herstellung einer injektionsloesung
JPH02500591A (ja) * 1987-05-27 1990-03-01 アクゾ・エヌ・ヴエー β‐ラクタム抗生物質の乾燥した急速溶解性の組成物
IE61679B1 (en) * 1987-08-10 1994-11-16 Fujisawa Pharmaceutical Co Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
AU687276B2 (en) * 1994-12-08 1998-02-19 Otsuka Pharmaceutical Factory, Inc. Method of suppressing adsorption of substances derived from container material on drugs and container
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
CA2239331C (en) * 1998-05-29 1999-11-30 Bernard Charles Sherman Pharmaceutical tablets comprising cefuroxime axetil
ES2686898T3 (es) 2003-04-28 2018-10-22 Takeda Pharmaceutical Company Limited Composición para inyección
JP4700291B2 (ja) * 2003-04-28 2011-06-15 武田薬品工業株式会社 注射用組成物
EP1625859A1 (en) * 2004-08-13 2006-02-15 Access Group ApS A process for the preparation of a package comprising a sterilised bulk of a substance, and a package comprising a sterilised bulk of a penicilin
CN102920710B (zh) * 2012-11-16 2014-05-28 罗诚 一种头孢地嗪化合物的药物组合物
CN103432137B (zh) * 2013-08-28 2015-01-28 芦红代 头孢西丁的药物组合物
CN113350511B (zh) * 2021-03-01 2024-01-02 郎俊娜 一种新型注射用无菌粉末灌装混合保护气
CN116588404A (zh) * 2022-12-31 2023-08-15 浙江惠迪森药业有限公司 注射用无菌粉末灌装保护气制作方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB760087A (en) * 1952-10-16 1956-10-31 Novo Terapeutisk Labor As Process of increasing the physical stability of aqueous suspensions of penicillin compounds
GB737242A (en) * 1952-10-16 1955-09-21 Novo Terapeutisk Labor As Process of increasing the physical stability of aqueous suspensions of penicillin compounds
GB1132583A (en) * 1964-12-16 1968-11-06 Glaxo Lab Ltd Pharmaceutical compositions containing cephalosporins
GB1276839A (en) * 1968-08-02 1972-06-07 Sandoz Products Ltd Antibiotic compositions
AT307616B (de) * 1969-05-02 1973-05-25 Biochemie Gmbh Verfahren zur Herstellung einer Brausezubereitung
GB1380741A (en) * 1971-02-05 1975-01-15 Squibb & Sons Inc Antibiotic compositions and their preparation
US3940483A (en) * 1971-02-05 1976-02-24 E. R. Squibb & Sons, Inc. Antibiotic compositions and method
LU65921A1 (sv) * 1972-08-18 1974-02-21
US4160829A (en) * 1972-12-22 1979-07-10 Gist-Brocades N.V. Antibacterial 1,2,4-oxadiazolylacetamido cephalosporins
US3969524A (en) * 1974-08-13 1976-07-13 Hoffmann-La Roche Inc. Stable amoxicillin dosage form
GB1463563A (en) * 1974-10-10 1977-02-02 Beecham Group Ltd Pharmaceutical compositions
DE2461969A1 (de) * 1974-12-31 1976-07-08 Behringwerke Ag Stabiles blutplasma, verfahren zu dessen herstellung und seine verwendung als vergleichsplasma bei gerinnungs- untersuchungen
CA1051780A (en) * 1975-04-09 1979-04-03 Bahram Farhadieh Stable chelocardin composition
GB1575905A (en) * 1976-04-28 1980-10-01 Glaxo Lab Ltd Salt of cefuroxime
GB1504767A (en) * 1976-08-23 1978-03-22 Beecham Group Ltd Antibiotic compositions
JPS5329936A (en) * 1976-08-31 1978-03-20 Takeda Chem Ind Ltd Antibiotic composition
FR2403078A1 (fr) * 1977-09-19 1979-04-13 Lafon Labor Nouveau procede de preparation de formes pharmaceutiques, cosmetiques ou de diagnostic
JPS5473790A (en) * 1977-10-10 1979-06-13 Glaxo Group Ltd Betaalactam compound and manufacture
AR228726A1 (es) * 1978-05-26 1983-04-15 Glaxo Group Ltd Procedimiento para la preparacion del antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)acetamido)-3-(1-piridiniometil)cef-3-em-4-carboxilato
PT70225A (en) * 1978-10-03 1979-10-01 Gist Brocades Nv Process for the preparation of sodium amoxicillin preparations
US4235900A (en) * 1978-11-15 1980-11-25 E. R. Squibb & Sons, Inc. Cephradine compositions
FR2445833A1 (fr) * 1979-01-04 1980-08-01 Chimie Biolog Nouveaux sels d'antibiotiques amines a cycle beta lactame
US4329453A (en) * 1979-10-02 1982-05-11 Glaxo Group Limited Cephalosporin antibiotic

Also Published As

Publication number Publication date
PT77323A (en) 1983-10-01
US4582830A (en) 1986-04-15
DE3332616C2 (de) 1995-06-01
KR880001094B1 (ko) 1988-06-29
ES8502863A1 (es) 1985-02-01
IT8348950A1 (it) 1985-03-09
ZA836703B (en) 1984-10-31
FR2532849A1 (fr) 1984-03-16
JPS5973518A (ja) 1984-04-25
SE464615B (sv) 1991-05-27
DK161304C (da) 1991-12-02
NL8303125A (nl) 1984-04-02
GB2126479B (en) 1986-04-03
DE3332616A1 (de) 1984-03-15
KR840006126A (ko) 1984-11-22
GB2126479A (en) 1984-03-28
JPH0480883B2 (sv) 1992-12-21
IE832118L (en) 1984-03-10
IT8348950A0 (it) 1983-09-09
FR2532849B1 (fr) 1986-08-22
NZ205539A (en) 1986-03-14
SE8304857D0 (sv) 1983-09-09
CA1215647A (en) 1986-12-23
AT388671B (de) 1989-08-10
DK409183A (da) 1984-03-11
ES525492A0 (es) 1985-02-01
CH655008A5 (de) 1986-03-27
IE55720B1 (en) 1991-01-02
PT77323B (en) 1986-02-06
GB8324133D0 (en) 1983-10-12
US4803196A (en) 1989-02-07
AU566245B2 (en) 1987-10-15
DK161304B (da) 1991-06-24
DK409183D0 (da) 1983-09-09
NL189948B (nl) 1993-04-16
IT1197708B (it) 1988-12-06
ATA322783A (de) 1989-01-15
NL189948C (nl) 1993-09-16
AU1897583A (en) 1984-03-15
BE897721A (fr) 1984-03-09

Similar Documents

Publication Publication Date Title
SE8304857D0 (sv) Pharmaceutical compositions
ES2098842T3 (es) Composicion farmaceutica estabilizada y disolvente estabilizante.
ES8500064A1 (es) Un metodo de esterilizar superficies, especialmente superficies de utiles empleados comunmente en medicina
ATE179612T1 (de) Hochdosierte topische kollagenaseformen
SE8700499L (sv) Nya farmakologiskt aktiva foreningar
ES2082011T3 (es) Procedimiento y composicion para extinguir fuegos.
FR2591485B1 (fr) Compositions stabilisees contenant l'activateur du plasminogene du tissu humain.
ES443840A1 (es) Procedimiento para la preparacion de un plasma sanguineo.
ATA186692A (de) Pharmazeutische zusammensetzung
ATE6907T1 (de) Zahncreme mit hohem schaumvermoegen.
SE7703206L (sv) Stabiliserad ureas
DE59811270D1 (de) Zusammensetzung enthaltend feine feststoffteilchen
FR2425856B1 (sv)
JO1337B1 (en) Pharmaceutical compounds
ATE65025T1 (de) Kalziumkarbonatsuspension enthaltende pharmazeutische zusammensetzung.
SE8200757L (sv) Biologiskt aktiva peptider
ES2033501T3 (es) Procedimiento para la preparacion de polisulfuros de sodio inferiores a partir de polisulfuros de sodio superiores y sodio.
Yocom Materials as sinks and sources of indoor air pollution.
ATE33552T1 (de) Dermatologische praeparate.
ES2059387T3 (es) Concentrado de estabilizante mejorado.
DE60141632D1 (de) Zusammensetzung zur stabilisierung von fettlöslichen vitaminen in wässeriger lösung
AU494778B2 (en) Determining the concentration of gaseous components ina mixture of gases
BG49553A1 (en) Polyvinylchloride composition and method for its preparation
SU1125965A1 (ru) Трехкомпонентная фторидная солевая смесь
IT7868186A0 (it) Dispositivo e procedimento per la determinazione di composti alogenati di carbonio nei gas

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8304857-9

Format of ref document f/p: F

NUG Patent has lapsed